[1]蒙健林,陈雅璐,王明刚,等.大黄灵仙胶囊治疗胆石症的网络药理学研究[J].西部中医药,2024,37(11):50-55.[doi:10.12174/j.issn.2096-9600.2024.11.12]
　MENG Jianlin,CHEN Yalu,WANG Minggang,et al.Network Pharmacology-based Study of Daihuang Lingxian Capsules in the Treatment of Cholelithiasis[J].Western Journal of Traditional Chinese Medicine,2024,37(11):50-55.[doi:10.12174/j.issn.2096-9600.2024.11.12]
点击复制

大黄灵仙胶囊治疗胆石症的网络药理学研究
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
37
期数:
2024年11期
页码:
50-55
栏目:
二次研究
出版日期:
2024-11-15

文章信息/Info

Title:
Network Pharmacology-based Study of Daihuang Lingxian Capsules in the Treatment of Cholelithiasis
作者:
蒙健林1, 陈雅璐2, 王明刚2, 王兵2, 胡嗣钦2, 王清坚2
1.广西中医药大学，广西 南宁 530023
2.广西中医药大学第一附属医院，广西 南宁 530023
Author(s):
MENG Jianlin1, CHEN Yalu2, WANG Minggang2, WANG Bing2, HU Siqin2, WANG Qingjian2
1.Guangxi University of Chinese Medicine, Nanning 530023, China
2.The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning 530023, China
关键词:
大黄灵仙胶囊; 网络药理学; 胆石症; 靶点; 信号通路
Keywords:
capsules; network pharmacology; cholelithiasis; targets; signaling pathway
分类号:
R575.6
DOI:
10.12174/j.issn.2096-9600.2024.11.12
文献标志码:
A
摘要:
目的通过网络药理学方法分析大黄灵仙胶囊治疗胆石症的作用机制。 方法使用中药系统药理分析平台提取大黄灵仙胶囊的有效活性成分及对应作用靶点，结合UniProt数据库对靶点进行标准化。通过GeneCards数据库检索得到胆石症相关靶点，借助R语言筛选大黄灵仙胶囊与胆石症的交集靶点，借助Perl语言映射出交集靶点对应的有效活性成分，构建药物治疗疾病的“有效活性成分-靶点”数据库，利用Cytoscape软件对数据库绘制可视化图并筛选出核心有效成分；借助STRING数据库对交集靶点进行蛋白相互作用分析，DAVID数据库对交集靶点进行基因本体论（gene ontology，GO）功能富集分析和京都基因与基因组百科全书（kyoto encyclopedia of genes and genomes，KEGG）通路富集分析。 结果得到160个大黄灵仙胶囊有效活性成分，116个对应作用靶点，其中与胆石症的共同靶点28个。大黄灵仙胶囊治疗胆石症的核心成分有槲皮素、β-谷甾醇、山柰酚、异鼠李素等，治疗的主要核心靶点有白细胞介素6、血管内皮生长因子A、表皮生长因子受体等，主要通过细胞增殖调控、一氧化氮生物合成过程调控等生物作用在细胞核浆、内吞体膜、胞外间隙等细胞位置，发挥类固醇结合、酶结合、转录因子结合等分子功能参与调控癌变通路、缺氧诱导因子1（hypoxia inducible factor-1，HIF-1）信号通路等，发挥治疗胆石症的效用。 结论网络药理学构建了大黄灵仙胶囊治疗胆石症多活性成分、多基因靶点、多治疗通路相互作用的特点，筛选出大黄灵仙胶囊作用于胆石症的基因靶点和信号通路，为进一步探索大黄灵仙胶囊治疗胆石症的作用机制提供参考依据。
Abstract:
ObjectiveTo analyze the mechanism of Daihuang (radix et rhizoma rhei) Lingxian capsules in the treatment of cholelithiasis based on network pharmacology. MethodsTraditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) was applied to extract the active ingredients and the corresponding targets of action of the medicine, the standardization of the targets were conducted by combining with Uniprot database; cholelithiasis-related targets were searched from GeneCards database; the intersecting targets between the medicine and cholelithiasis were searched via R language, and the active ingredients corres-ponding with the intersecting targets were mapped out via Perl language, to construct the database of "active ingredients-targets" for the treatment of disease with the medicine, Cytoscape software was utilized to visualize the database and screen the core active ingredients; STRING database was applied to analyze protein-protein interaction (PPI) of the intersecting targets, DAVID database was used to perform GO and KEGG enrichment analysis of the intersecting targets. ResultsThe study has yielded 160 active ingredients of the medicine, 116 corresponding targets, and 28 targets shared with the disease. The core ingredients of the medicine for the treat-ment of cholelithiasis contained quercetin, β-Sitosterol, kaempferol and isorhamnetin, and the main core targets of the treatment were IL-6, VEGFA and EGFR, these ingredients participated in the regulation of the oncogenic pathway, hypoxia inducible factor-1 (HIF-1) signaling pathway by developing steroid-binding, enzyme-binding, transcription factor-binding and other molecular functions, mainly through the regulation of cell proliferation, nitric oxide biosynthesis process and other biological effects in the cell nucleus plasma, endosomal membrane, extracellular space and other cells, thus treating cholelithiasis. ConclusionNetwork pharmacology has constructed the characteristics of multi-active components, multi-genetic targets and multi-therapeutic pathways of the capsules in the treatment of cholelithiasis, and screened out the genetic targets and signaling pathways of the medicine acting on cholelithiasis, which could produce the references for further exploration into the mechanism of the medicine in the treatment of cholelithiasis.

相似文献/References:

[1]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
　TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(11):21.[doi:10.12174/j.issn.2096-9600.2022.01.05]
[2]吴春凤,黄艳霞,郑景辉.基于网络药理学分析荆芥—防风药对的分子作用机制[J].西部中医药,2022,35(02):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
　WU Chunfeng,HUANG Yanxia,ZHENG Jinghui.Molecular Mechanism of Couplet Medicinals Jingjie‐Fangfeng Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(11):74.[doi:10.12174/j.issn.2096-9600.2022.02.18]
[3]陶鑫,薛中峰,覃骊兰.基于网络药理学的过敏煎治疗过敏性哮喘分子机制研究[J].西部中医药,2022,35(03):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
　TAO Xin,XUE Zhongfeng,QIN Lilan.Study on the Molecular Mechanism of Guomin Jian in the Treatment of Allergic Asthma Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(11):27.[doi:10.12174/j.issn.2096-9600.2022.03.07]
[4]黄康勤.基于网络药理学预测穿心莲内酯抗呼吸道感染的分子作用机制[J].西部中医药,2022,35(03):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
　HUANG Kangqin.Molecular Mechanism of Andrographolide against Respiratory Tract Infection Predicted by Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(11):33.[doi:10.12174/j.issn.2096-9600.2022.03.08]
[5]石威,张俊忠,解鹏超,等.基于网络药理学和分子对接探析淫羊藿-牛膝药对治疗股骨头坏死的作用机制[J].西部中医药,2022,35(04):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
　SHI Wei,ZHANG Junzhong,XIE Pengchao,et al.Study on the Mechanism of Yinyanghuo-Niuxi Drug Pair in Treating Femoral Head Necrosis Based on Network Pharmacology and Molecular Docking[J].Western Journal of Traditional Chinese Medicine,2022,35(11):35.[doi:10.12174/j.issn.2096-9600.2022.04.09]
[6]刘卓超,黄小靖,曾志聪.黄连生物碱改善心力衰竭的网络药理学机制研究[J].西部中医药,2022,35(04):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
　LIU Zhuochao,HUANG Xiaojing,ZENG Zhicong.Study on the Mechanism of Coptis Alkaloid in the Treatment of Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(11):42.[doi:10.12174/j.issn.2096-9600.2022.04.10]
[7]张维芯,周青,戴国梁,等.基于SARS-CoV-2关键蛋白ACE2探索“葛根-柴胡”治疗COVID-19的潜在机制[J].西部中医药,2022,35(05):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
　ZHANG Weixin,ZHOU Qing,DAI Guoliang,et al.The Potential Mechanism of “Gegen-Chaihu” in the Treatment of COVID-19 Based on SARS-CoV-2 Target Protein ACE2[J].Western Journal of Traditional Chinese Medicine,2022,35(11):1.[doi:10.12174/j.issn.2096-9600.2022.05.01]
[8]林鑫,刘阳,陈林伟,等.基于网络药理学探讨气血双补方抗慢性心力衰竭的作用机制[J].西部中医药,2022,35(06):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
　LIN Xin,LIU Yang,CHEN Linwei,et al.Study on the Mechanism of Qixue Shuangbu Prescription in Treating Chronic Heart Failure Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(11):29.[doi:10.12174/j.issn.2096-9600.2022.06.08]
[9]潘威.基于网络药理学探讨大黄治疗溃疡性结肠炎的机制[J].西部中医药,2022,35(06):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
　PAN Wei.The Mechanism of Dahuang in Treating Ulcerative Colitis Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(11):80.[doi:10.12174/j.issn.2096-9600.2022.06.21]
[10]李磊,宁南义,王小龙,等.基于网络药理学的新型冠状病毒肺炎核心中药靶标预测及其作用机制研究?[J].西部中医药,2021,34(11):10.[doi:10.12174/j.issn.2096-9600.2021.11.03]
　LI Lei,NING Nanyi,WANG Xiaolong,et al.The Study on the Mechanism and Target Prediction of Core Herbs of COVID-19 Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2021,34(11):10.[doi:10.12174/j.issn.2096-9600.2021.11.03]

备注/Memo

备注/Memo:
蒙健林（1996—），女，硕士学位，助教。研究方向：中西医结合临床与基础研究。国家自然科学基金（82060867，82474507）；广西自然科学基金重点项目（2024GXNSFDA010025）；广西名中医传承工作室建设项目（GZY2024011）。
更新日期/Last Update: 2024-11-15